GD Stewart has received educational grants from Pfizer and Intuitive Surgical; consultancy fees from Pfizer, EUSA Pharma and Cambridge Medical Robotics; Travel expenses from Pfizer and Speaker fees from Pfizer. RA Figlin has received research funding from Peloton, BMS, Argos Therapeutics, Exilexis, and Cerulean; consulting fees from Novartis, Pfizer, Nektar, Peloton, Calithera, and Acceleron. S Negrier reports honoraria from Pfizer, Novartis, EUSA Pharma, Ipsen Biotech and Bristol-Myers Squibb. BC Leibovich declares no conflicts of interest.

中文翻译：

---

佐剂帕唑帕尼不能预防高危、最初局部肾细胞癌的复发，但确实提供了新的见解

GD Stewart 获得了辉瑞和 Intuitive Surgical 的教育资助；辉瑞、EUSA Pharma 和 Cambridge Medical Robotics 的咨询费；辉瑞的差旅费和辉瑞的演讲者费用。RA Figlin 已获得 Peloton、BMS、Argos Therapeutics、Exilexis 和 Cerulean 的研究资助；诺华、辉瑞、Nektar、Peloton、Calithera 和 Acceleron 的咨询费。S Negrier 报道了辉瑞、诺华、EUSA Pharma、Ipsen Biotech 和 Bristol-Myers Squibb 的酬金。BC Leibovich 声明没有利益冲突。